Obtaining a DEA license to manufacture any drugs in schedule one is a difficult challenge. Very few people in the US have been able to crack the code except large pharmaceutical companies and rare other for-profit entities. It is urgent we seek to open access to MDMA- and psilocybin-assisted therapy for Veterans and other trauma victims who are at serious risk of suicide and have exhausted all other options.
1000s of Veterans/first responders who nearly lost all hope after struggling through (sometimes double digit) ineffective medications and therapies – which often left them worse off than where they started – are forced to seek plant medicines and other psychedelics on the illicit market. But there are methods to apply for a DEA Schedule 1 manufacturing license independently.
Additional Supporting Materials
Other Resources / Information
- There are ways for individuals to apply for their own DEA schedule 1 manufacturing license to cultivate their own plant medicine/psychedelics
- There are existing DEA manufacturers that are willing to partner on cultivation if you are not interested in applying for your own license
- Developing analytical methods for potency testing in whole psilocybin mushrooms—keeping that guidance open source for scientist to replicate globally
- Sue Sisley, MD, President/Principal Investigator, Scottsdale Research Institute/Field To Healed Foundation
- Rick Doblin, Executive Director, Multi-disciplinary association of Psychedelic Studies MAPS
- Cristala Mussato-Allen, President, Native workplace
Sue Sisley, MD, President/Principal Investigator, Scottsdale Research Institute/Field To Healed Foundation
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.